Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

Norwegian patients and retail chicken meat share cephalosporin-resistant Escherichia coli and IncK/blaCMY-2 resistance plasmids.

Berg ES, Wester AL, Ahrenfeldt J, Mo SS, Slettemeås JS, Steinbakk M, Samuelsen Ø, Grude N, Simonsen GS, Løhr IH, Jørgensen SB, Tofteland S, Lund O, Dahle UR, Sunde M.

Clin Microbiol Infect. 2017 Jun;23(6):407.e9-407.e15. doi: 10.1016/j.cmi.2016.12.035. Epub 2017 Jan 7.

PMID:
28082191
2.

Carriage of ESBL/AmpC-producing or ciprofloxacin non-susceptible Escherichia coli and Klebsiella spp. in healthy people in Norway.

Ulstad CR, Solheim M, Berg S, Lindbæk M, Dahle UR, Wester AL.

Antimicrob Resist Infect Control. 2016 Dec 15;5:57. doi: 10.1186/s13756-016-0156-x. eCollection 2016.

3.

Plasmid-mediated colistin-resistant Escherichia coli detected from 2014 in Norway.

Solheim M, Bohlin J, Ulstad CR, Schau Slettemeås J, Naseer U, Dahle UR, Wester AL.

Int J Antimicrob Agents. 2016 Aug;48(2):227-8. doi: 10.1016/j.ijantimicag.2016.06.001. Epub 2016 Jun 22. No abstract available.

PMID:
27388575
4.

Norwegian public health investigation shows that antibiotic resistance concerns us all.

Dahle UR, Ulstad C, Berg S.

BMJ. 2015 Jul 29;351:h4055. doi: 10.1136/bmj.h4055. No abstract available.

PMID:
26223775
5.

Description of the largest cluster of tuberculosis notified in Norway 1997-2011: is the Norwegian tuberculosis control programme serving its purpose for high risk groups?

Guzman Herrador BR, Rønning K, Borgen K, Mannsåker T, Dahle UR.

BMC Public Health. 2015 Apr 11;15:367. doi: 10.1186/s12889-015-1701-x.

6.

Towards tuberculosis elimination: an action framework for low-incidence countries.

Lönnroth K, Migliori GB, Abubakar I, D'Ambrosio L, de Vries G, Diel R, Douglas P, Falzon D, Gaudreau MA, Goletti D, González Ochoa ER, LoBue P, Matteelli A, Njoo H, Solovic I, Story A, Tayeb T, van der Werf MJ, Weil D, Zellweger JP, Abdel Aziz M, Al Lawati MR, Aliberti S, Arrazola de Oñate W, Barreira D, Bhatia V, Blasi F, Bloom A, Bruchfeld J, Castelli F, Centis R, Chemtob D, Cirillo DM, Colorado A, Dadu A, Dahle UR, De Paoli L, Dias HM, Duarte R, Fattorini L, Gaga M, Getahun H, Glaziou P, Goguadze L, Del Granado M, Haas W, Järvinen A, Kwon GY, Mosca D, Nahid P, Nishikiori N, Noguer I, O'Donnell J, Pace-Asciak A, Pompa MG, Popescu GG, Robalo Cordeiro C, Rønning K, Ruhwald M, Sculier JP, Simunović A, Smith-Palmer A, Sotgiu G, Sulis G, Torres-Duque CA, Umeki K, Uplekar M, van Weezenbeek C, Vasankari T, Vitillo RJ, Voniatis C, Wanlin M, Raviglione MC.

Eur Respir J. 2015 Apr;45(4):928-52. doi: 10.1183/09031936.00214014. Review.

7.

Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient.

Eldholm V, Norheim G, von der Lippe B, Kinander W, Dahle UR, Caugant DA, Mannsåker T, Mengshoel AT, Dyrhol-Riise AM, Balloux F.

Genome Biol. 2014 Nov 7;15(11):490. doi: 10.1186/s13059-014-0490-3.

8.

Evaluation of the ability of four ESBL-screening media to detect ESBL-producing Salmonella and Shigella.

Sturød K, Dahle UR, Berg ES, Steinbakk M, Wester AL.

BMC Microbiol. 2014 Sep 4;14:217. doi: 10.1186/s12866-014-0217-3.

9.

An outbreak of enterotoxigenic Escherichia coli (ETEC) infection in Norway, 2012: a reminder to consider uncommon pathogens in outbreaks involving imported products.

MacDonald E, Møller KE, Wester AL, Dahle UR, Hermansen NO, Jenum PA, Thoresen L, Vold L.

Epidemiol Infect. 2015 Feb;143(3):486-93. doi: 10.1017/S0950268814001058. Epub 2014 May 9.

PMID:
24813906
10.

Extraintestinal pathogenic Escherichia coli carrying the Shiga Toxin gene stx2.

Wester AL, Brandal LT, Dahle UR.

J Clin Microbiol. 2013 Dec;51(12):4279-80. doi: 10.1128/JCM.01349-13. Epub 2013 Oct 9. No abstract available.

11.

Age-related differences in symptoms, diagnosis and prognosis of bacteremia.

Wester AL, Dunlop O, Melby KK, Dahle UR, Wyller TB.

BMC Infect Dis. 2013 Jul 24;13:346. doi: 10.1186/1471-2334-13-346.

12.

Incentives for developing new antibiotics or antimicrobial strategies.

Dahle UR, Petersen FC.

BMJ. 2013 Apr 8;346:f2136. doi: 10.1136/bmj.f2136. No abstract available.

PMID:
23568793
13.

[Last chance for effective antibiotics?].

Dahle UR, Wester AL, Samuelsen Ø, Sundsfjord A.

Tidsskr Nor Laegeforen. 2012 Aug 21;132(15):1725-6. doi: 10.4045/tidsskr.12.0565. Norwegian. No abstract available.

14.

[Totally drug resistant tuberculosis?].

Dahle UR.

Tidsskr Nor Laegeforen. 2012 Mar 27;132(6):634. doi: 10.4045/tidsskr.12.0168. Norwegian. No abstract available.

15.

Genetic diversity of Mycobacterium tuberculosis Complex in Jos, Nigeria.

Ani A, Bruvik T, Okoh Y, Agaba P, Agbaji O, Idoko J, Dahle UR.

BMC Infect Dis. 2010 Jun 26;10:189. doi: 10.1186/1471-2334-10-189.

16.

Dominant Mycobacterium tuberculosis lineages in elderly patients born in Norway.

Kinander W, Bruvik T, Dahle UR.

PLoS One. 2009 Dec 18;4(12):e8373. doi: 10.1371/journal.pone.0008373.

17.

Molecular epidemiology and drug resistance of widespread genotypes of Mycobacterium tuberculosis in northwestern Russia.

Baranov AA, Mariandyshev AO, Mannsåker T, Dahle UR, Bjune GA.

Int J Tuberc Lung Dis. 2009 Oct;13(10):1288-93.

PMID:
19793435
18.

Joining the DOTS: National "twin study".

Dahle UR.

BMJ. 2008 Mar 15;336(7644):574. doi: 10.1136/bmj.39514.423090.80. No abstract available.

19.

Impact of immigration on the molecular epidemiology of Mycobacterium tuberculosis in a low-incidence country.

Dahle UR, Eldholm V, Winje BA, Mannsåker T, Heldal E.

Am J Respir Crit Care Med. 2007 Nov 1;176(9):930-5. Epub 2007 Aug 2.

PMID:
17673698
20.

Drug resistance of Mycobacterium tuberculosis in the Sunamganj District of Bangladesh.

Storla DG, Rahim Z, Islam MA, Plettner S, Begum V, Myrvang B, Bjune G, Rønnild E, Dahle UR, Mannsåker T.

Scand J Infect Dis. 2007;39(2):142-5.

PMID:
17366031

Supplemental Content

Loading ...
Support Center